Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Efficacy And Safety Of Re-Treatment With Varenicline In Subjects Who Are Currently Smoking, And Who Have Previously Taken Varenicline

NCT01244061 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01244061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01244061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Efficacy And Safety Of Re-Treatment With Varenicline In Subjects Who Are Currently Smoking, And Who Have Previously Taken Varenicline
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
November 30, 2012
Enrollment
498 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation